Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Tanezumab Chemical Structure
BCP42767 Tanezumab 880266-57-9
Tanezumab is a humanized IgG2 monoclonal antibody directed against nerve growth factor that blocks the interaction of nerve growth factor with its receptors, TrkA and p75.
Emicizumab Chemical Structure
BCP42773 Emicizumab 1610943-06-0
Emicizumab is a bispecific monoclonal antibody that bridges activated factor IX and factor X to replace the function of missing activated factor VIII, thereby restoring hemostasis.
Margetuximab Chemical Structure
BCP42093 Margetuximab 1350624-75-7
Margetuximab, a novel, investigational, Fc-engineered, anti-HER2 monoclonal antibody, is designed to more effectively potentiate innate immunity than trastuzumab.
Anifrolumab Chemical Structure
BCP42092 Anifrolumab 1326232-46-5
Anifrolumab, a human monoclonal antibody.
Tovetumab Chemical Structure
BCP42095 Tovetumab 1243266-04-7
Tovetumab is a fully human IgG2κ monoclonal antibody.
Anetumab Ravtansine Chemical Structure
BCP42094 Anetumab Ravtansine 1375258-01-7
Anetumab ravtansine is an antibody-drug conjugate of anti-mesothelin antibody linked to maytansinoid DM4
Lifastuzumab Vedotin Chemical Structure
BCP40933 Lifastuzumab Vedotin 1401812-88-1
Lifastuzumab vedotin (LIFA) is an antibody-drug conjugate of anti-NaPi2b mAb (MNIB2126A) and a potent antimitotic agent (monomethyl auristatin E).
Ruplizumab Chemical Structure
BCP40934 Ruplizumab 220651-94-5
Ruplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of Antova.
Sasanlimab Chemical Structure
BCP40874 Sasanlimab 2206792-50-7
Enfortumab Vedotin Chemical Structure
BCP40770 Enfortumab Vedotin 1346452-25-2
Enfortumab vedotin is an antibody-drug conjugate comprised of multiple components.
123下一页末页共 80 条记录 1 / 8 页 
0086-15971444841